Martin J J, Guazzi G C
Born-Bunge Foundation, University of Antwerp, Belgium.
Dev Neurosci. 1991;13(4-5):267-73. doi: 10.1159/000112172.
The natural history and the evolution of the concept of Schilder's diffuse sclerosis have been described by Poser and van Bogaert in 1956 and there is really not much to add to their analysis. The major progress made in the clinical, genetic, enzymatic and biochemical workup of many of the conditions previously grouped under the denomination of Schilder's disease confirms its heterogeneity. We will discuss (1) the myelinoclastic disorders; (2) the leukodystrophies with disorders such as adrenoleukodystrophy and the still very ill-defined sudanophilic leukodystrophies; (3) the subacute sclerosing leukoencephalitis, better known today as the subacute sclerosing panencephalitis. In conclusion, the name of Schilder is to be remembered as are all the names of the great neurologists and neuropathologists of the past but it would be better to avoid nowadays the eponym of Schilder's disease in order to prevent confusion between different disorders.
波泽尔(Poser)和范·博加特(van Bogaert)于1956年描述了席尔德弥漫性硬化症的自然史及该概念的演变,实际上对于他们的分析已没有太多可补充的内容。此前归为席尔德病名下的许多病症,在临床、遗传学、酶学及生物化学检查方面取得的重大进展证实了其异质性。我们将讨论:(1)脱髓鞘疾病;(2)脑白质营养不良,如肾上腺脑白质营养不良以及定义仍非常不明确的嗜苏丹脑白质营养不良等病症;(3)亚急性硬化性全脑炎,如今更广为人知的名称是亚急性硬化性全脑炎。总之,席尔德这个名字应与过去所有伟大的神经科医生和神经病理学家的名字一样被铭记,但如今最好避免使用席尔德病这个以人名命名的疾病名称,以免造成不同病症之间的混淆。